LCBiot-FQDAYNAAGGHNAVF-OH

Ref. 3D-PP42966

Informations sur le produit

• Nom: LCBiot-FQDAYNAAGGHNAVF-OH
• Synonymes: LCBiot-Phe-Gln-Asp-Ala-Tyr-Asn-Ala-Ala-Gly-Gly-His-Asn-Ala-Val-Phe-OH

Description

Peptide LCBiot-FQDAYNAAGGHNAVF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-FQDAYNAAGGHNAVF-OH include the following: Influence of Mycobacterium avium subsp. paratuberculosis on Colitis Development and Specific Immune Responses during Disease UP Singh , S Singh , R Singh , RK Karls - Infection and , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.01770-06 Exploiting pre-existing CD4+ T cell help from bacille calmette-guerin vaccination to improve antiviral antibody responses TW Ng , AS Wirchnianski, AZ Wec , JM Fels - The Journal of , 2020 - journals.aai.orghttps://journals.aai.org/jimmunol/article/205/2/425/110188 The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model T Tamura, H Ariga, T Kinashi, S Uehara - International , 2004 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/16/12/1691/657375 TLR2 engagement on CD4+ T cells enhances effector functions and protective responses to Mycobacterium tuberculosis SM Reba, Q Li, S Onwuzulike, X Ding - European journal of , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201344100 Generation of IL-3-Secreting CD4+ T Cells by Microbial Challenge at Skin and Mucosal Barriers S Kunnath-Velayudhan , MF Goldberg, NK Saini - , 2019 - journals.aai.orghttps://journals.aai.org/immunohorizons/article/3/5/161/3787 CD8 T cells show protection against highly pathogenic simian immunodeficiency virus (SIV) after vaccination with SIV gene-expressing BCG prime and vaccinia virus S Kato, H Shida, T Okamura, X Zhang, T Miura - Journal of , 2021 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01718-20 The type of growth medium affects the presence of a mycobacterial capsule and is associated with differences in protective efficacy of BCG vaccination against R Prados-Rosales , LJ Carre - The Journal of , 2016 - academic.oup.comhttps://academic.oup.com/jid/article-abstract/214/3/426/2577359 Enhanced priming of adaptive immunity by Mycobacterium smegmatis mutants with high-level protein secretion N Taylor, F Bahunde, A Thompson, JS Yu - Clinical and Vaccine , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/cvi.00131-12 In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG MM Venkataswamy , MF Goldberg, A Baena , J Chan - Vaccine, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X11019670 Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation L Barbier , SS Tay, C McGuffog, JA Triccas - Journal of , 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168827812002784 A hepatic network of dendritic cells mediates CD4 T cell help outside lymphoid organs K English, R Kwan, LE Holz , C McGuffog - Nature , 2024 - nature.comhttps://www.nature.com/articles/s41467-024-45612-5 Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory JK Nambiar, R Pinto, JI Aguilo - European journal of , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201141903 Limited antimycobacterial efficacy of epitope peptide administration despite enhanced antigen-specific CD4 T-cell activation JD Ernst, A Cornelius, L Desvignes - The Journal of , 2018 - academic.oup.comhttps://academic.oup.com/jid/article-abstract/218/10/1653/4935307 Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 G Prota, D Christensen , P Andersen , D Medaglini - Vaccine, 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X15012906 BATF2 promotes HSC myeloid differentiation by amplifying IFN response mediators during chronic infection DT Le, MA Florez , P Kus, BT Tran, B Kain , Y Zhu - Iscience, 2023 - cell.comhttps://www.cell.com/iscience/pdf/S2589-0042(23)00136-0.pdf Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune DJ Dowling , EA Scott , A Scheid, I Bergelson - Journal of Allergy and , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0091674917302427 Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis C Counoupas , R Pinto, G Nagalingam, WJ Britton - Vaccine, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X18304353 T follicular helper and T follicular regulatory cells have different TCR specificity AR Maceiras , SCP Almeida , E Mariotti-Ferrandiz - Nature , 2017 - nature.comhttps://www.nature.com/articles/ncomms15067/1000 Memory Th1 cells augment tumor-specific CTL following transcutaneous peptide immunization A Hosoi, Y Takeda, Y Furuichi, M Kurachi, K Kimura - Cancer Research, 2008 - AACRhttps://aacrjournals.org/cancerres/article-abstract/68/10/3941/540909 Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the A Ciabattini , G Prota, D Christensen - Frontiers in , 2015 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2015.00430

• Marque: Biosynth